Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 163

1.

Development of a test that measures real-time HER2 signaling function in live breast cancer cell lines and primary cells.

Huang Y, Burns DJ, Rich BE, MacNeil IA, Dandapat A, Soltani SM, Myhre S, Sullivan BF, Lange CA, Furcht LT, Laing LG.

BMC Cancer. 2017 Mar 16;17(1):199. doi: 10.1186/s12885-017-3181-0.

2.

A functional signal profiling test for identifying a subset of HER2-negative breast cancers with abnormally amplified HER2 signaling activity.

Huang Y, Burns DJ, Rich BE, MacNeil IA, Dandapat A, Soltani SM, Myhre S, Sullivan BF, Furcht LT, Lange CA, Hurvitz SA, Laing LG.

Oncotarget. 2016 Nov 29;7(48):78577-78590. doi: 10.18632/oncotarget.12480.

3.

Paradoxical roles for antioxidants in tumor prevention and eradication.

De Larco JE, Park CA, Dronava H, Furcht LT.

Cancer Biol Ther. 2010 Mar 1;9(5):362-70. Epub 2010 Mar 8.

PMID:
20038821
4.

NIH funding: what does the future look like?

Furcht LT.

Science. 2007 Apr 13;316(5822):198-200; author reply 198-200. No abstract available.

PMID:
17431152
5.

Financial disclosure policies of scientific publications.

Brockway LM, Furcht LT.

JAMA. 2006 Dec 27;296(24):2925-6; author reply 2926. No abstract available.

PMID:
17190892
6.

Conflicts of interest in biomedical research--the FASEB guidelines.

Brockway LM, Furcht LT; FASEB.

FASEB J. 2006 Dec;20(14):2435-8.

PMID:
17142792
7.

The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8.

De Larco JE, Wuertz BR, Furcht LT.

Clin Cancer Res. 2004 Aug 1;10(15):4895-900.

8.

Membrane type-1 matrix metalloproteinase promotes human melanoma invasion and growth.

Iida J, Wilhelmson KL, Price MA, Wilson CM, Pei D, Furcht LT, McCarthy JB.

J Invest Dermatol. 2004 Jan;122(1):167-76.

9.

Atypical methylation of the interleukin-8 gene correlates strongly with the metastatic potential of breast carcinoma cells.

De Larco JE, Wuertz BR, Yee D, Rickert BL, Furcht LT.

Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):13988-93. Epub 2003 Nov 17.

10.

Manipulation of hyaluronan synthase expression in prostate adenocarcinoma cells alters pericellular matrix retention and adhesion to bone marrow endothelial cells.

Simpson MA, Wilson CM, Furcht LT, Spicer AP, Oegema TR Jr, McCarthy JB.

J Biol Chem. 2002 Mar 22;277(12):10050-7. Epub 2002 Jan 14.

11.

Progression and enhancement of metastatic potential after exposure of tumor cells to chemotherapeutic agents.

De Larco JE, Wuertz BR, Manivel JC, Furcht LT.

Cancer Res. 2001 Apr 1;61(7):2857-61.

12.

Hyaluronan synthase elevation in metastatic prostate carcinoma cells correlates with hyaluronan surface retention, a prerequisite for rapid adhesion to bone marrow endothelial cells.

Simpson MA, Reiland J, Burger SR, Furcht LT, Spicer AP, Oegema TR Jr, McCarthy JB.

J Biol Chem. 2001 May 25;276(21):17949-57. Epub 2001 Mar 5.

13.

Melanoma chondroitin sulfate proteoglycan regulates matrix metalloproteinase-dependent human melanoma invasion into type I collagen.

Iida J, Pei D, Kang T, Simpson MA, Herlyn M, Furcht LT, McCarthy JB.

J Biol Chem. 2001 Jun 1;276(22):18786-94. Epub 2001 Mar 6.

14.

A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells.

De Larco JE, Wuertz BR, Rosner KA, Erickson SA, Gamache DE, Manivel JC, Furcht LT.

Am J Pathol. 2001 Feb;158(2):639-46.

15.

Enhancement of nigral graft survival in rat brain with the systemic administration of synthetic fibronectin peptide V.

Duan WM, Zhao LR, Westerman M, Lovick D, Furcht LT, McCarthy JB, Low WC.

Neuroscience. 2000;100(3):521-30.

PMID:
11098115
16.

Melanoma chondroitin sulphate proteoglycan regulates cell spreading through Cdc42, Ack-1 and p130cas.

Eisenmann KM, McCarthy JB, Simpson MA, Keely PJ, Guan JL, Tachibana K, Lim L, Manser E, Furcht LT, Iida J.

Nat Cell Biol. 1999 Dec;1(8):507-13.

17.

CXC-chemokines stimulate invasion and chemotaxis in prostate carcinoma cells through the CXCR2 receptor.

Reiland J, Furcht LT, McCarthy JB.

Prostate. 1999 Oct 1;41(2):78-88.

PMID:
10477904
18.

A role of chondroitin sulfate glycosaminoglycan binding site in alpha4beta1 integrin-mediated melanoma cell adhesion.

Iida J, Meijne AM, Oegema TR Jr, Yednock TA, Kovach NL, Furcht LT, McCarthy JB.

J Biol Chem. 1998 Mar 6;273(10):5955-62.

20.

Industry--a vital partner for academic medicine.

Furcht LT.

Hum Pathol. 1997 Oct;28(10):1117-22. No abstract available.

PMID:
9343316
21.

Inhibition of melanoma cell binding to type IV collagen by analogs of cell adhesion regulator.

Lauer JL, Furcht LT, Fields GB.

J Med Chem. 1997 Sep 12;40(19):3077-84.

PMID:
9301671
22.

Laminin peptide ameliorates brain injury by inhibiting leukocyte accumulation in a rat model of transient focal cerebral ischemia.

Yanaka K, Camarata PJ, Spellman SR, Skubitz AP, Furcht LT, Low WC.

J Cereb Blood Flow Metab. 1997 Jun;17(6):605-11.

PMID:
9236717
23.

Antagonism of leukocyte adherence by synthetic fibronectin peptide V in a rat model of transient focal cerebral ischemia.

Yanaka K, Camarata PJ, Spellman SR, McCarthy JB, Furcht LT, Low WC.

Neurosurgery. 1997 Mar;40(3):557-63; discussion 563-4.

PMID:
9055296
24.

Neuronal protection from cerebral ischemia by synthetic fibronectin peptides to leukocyte adhesion molecules.

Yanaka K, Camarata PJ, Spellman SR, McCarthy JB, Furcht LT, Low WC, Heros RC.

J Cereb Blood Flow Metab. 1996 Nov;16(6):1120-5.

PMID:
8898683
25.

Platelet adhesion to novel phospholipid materials: modified phosphatidylcholine covalently immobilized to silica, polypropylene, and PTFE materials.

Köhler AS, Parks PJ, Mooradian DL, Rao GH, Furcht LT.

J Biomed Mater Res. 1996 Oct;32(2):237-42.

PMID:
8884501
26.

Synthetic fibronectin peptides and ischemic brain injury after transient middle cerebral artery occlusion in rats.

Yanaka K, Camarata PJ, Spellman SR, McCarthy JB, Furcht LT, Low WC, Heros RC.

J Neurosurg. 1996 Jul;85(1):125-30.

PMID:
8683261
27.

Cell surface chondroitin sulfate proteoglycans in tumor cell adhesion, motility and invasion.

Iida J, Meijne AM, Knutson JR, Furcht LT, McCarthy JB.

Semin Cancer Biol. 1996 Jun;7(3):155-62. Review.

PMID:
8773301
28.

Promotion of fibroblast adhesion by triple-helical peptide models of type I collagen-derived sequences.

Grab B, Miles AJ, Furcht LT, Fields GB.

J Biol Chem. 1996 May 24;271(21):12234-40.

29.

The effect of lovastatin on [3H]thymidine uptake in HTC-4 and LLC-L1 tumor cells.

Morris TJ, Palm SL, Furcht LT, Buchwald H.

J Surg Res. 1996 Mar;61(2):367-72.

PMID:
8656610
30.

A peptide model of basement membrane collagen alpha 1 (IV) 531-543 binds the alpha 3 beta 1 integrin.

Miles AJ, Knutson JR, Skubitz AP, Furcht LT, McCarthy JB, Fields GB.

J Biol Chem. 1995 Dec 8;270(49):29047-50.

31.

Identification of a homologous heparin binding peptide sequence present in fibronectin and the 70 kDa family of heat-shock proteins.

Hansen LK, O'Leary JJ, Skubitz AP, Furcht LT, McCarthy JB.

Biochim Biophys Acta. 1995 Sep 27;1252(1):135-45.

PMID:
7548155
33.
34.
35.
37.

Synthetic fibronectin peptides suppress arthritis in rats by interrupting leukocyte adhesion and recruitment.

Wahl SM, Allen JB, Hines KL, Imamichi T, Wahl AM, Furcht LT, McCarthy JB.

J Clin Invest. 1994 Aug;94(2):655-62.

38.

Tenascin-R (J1 160/180 inhibits fibronectin-mediated cell adhesion--functional relatedness to tenascin-C.

Pesheva P, Probstmeier R, Skubitz AP, McCarthy JB, Furcht LT, Schachner M.

J Cell Sci. 1994 Aug;107 ( Pt 8):2323-33.

39.

Tumor cell invasion, matrix metalloproteinases, and the dogma.

Furcht LT, Skubitz AP, Fields GB.

Lab Invest. 1994 Jun;70(6):781-3. Review. No abstract available.

PMID:
8015282
40.

Synthetic fibronectin peptides interrupt inflammatory cell infiltration in transforming growth factor beta 1 knockout mice.

Hines KL, Kulkarni AB, McCarthy JB, Tian H, Ward JM, Christ M, McCartney-Francis NL, Furcht LT, Karlsson S, Wahl SM.

Proc Natl Acad Sci U S A. 1994 May 24;91(11):5187-91.

41.
42.

Structural features of fibronectin synthetic peptide FN-C/H II, responsible for cell adhesion, neurite extension, and heparan sulfate binding.

Drake SL, Varnum J, Mayo KH, Letourneau PC, Furcht LT, McCarthy JB.

J Biol Chem. 1993 Jul 25;268(21):15859-67.

43.

Human keratinocytes adhere to and spread on synthetic peptide FN-C/H-V derived from fibronectin.

Wilke MS, Vespa J, Skubitz AP, Furcht LT, McCarthy JB.

J Invest Dermatol. 1993 Jul;101(1):43-8.

44.
45.

Characterization of FN-C/H-V, a novel synthetic peptide from fibronectin that promotes rabbit corneal epithelial cell adhesion, spreading, and motility.

Mooradian DL, McCarthy JB, Skubitz AP, Cameron JD, Furcht LT.

Invest Ophthalmol Vis Sci. 1993 Jan;34(1):153-64.

PMID:
8425821
46.

The emerging role of molecular diagnostics in surgical pathology.

Furcht LT, McGlennen RC.

Hum Pathol. 1992 Nov;23(11):1197-8. No abstract available.

PMID:
1427747
47.

Rabbit corneal epithelial cells adhere to two distinct heparin-binding synthetic peptides derived from fibronectin.

Mooradian DL, McCarthy JB, Cameron JD, Skubitz AP, Furcht LT.

Invest Ophthalmol Vis Sci. 1992 Oct;33(11):3034-40.

PMID:
1399408
48.
50.

Supplemental Content

Loading ...
Support Center